Market Overview:
The global respiratory drug market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of respiratory diseases, growing awareness about respiratory drugs, and rising demand for advanced therapies. The global respiratory drug market is segmented on the basis of type into inhalable & nasal spray, oral, and others. Inhalable & nasal spray is expected to account for the largest share in terms of revenue in 2018 owing to their high usage rates across all regions. Oral drugs are also expected to witness significant growth during the forecast period due to their advantages over other types of drugs such as ease-of-use and lower side effects. On the basis of application, hospital accounted for the largest share in 2017 and is projected to maintain its dominance during the forecast period due its widespread use for treating various respiratory diseases.
Product Definition:
A respiratory drug is a medication that is used to treat or prevent respiratory diseases, such as bronchitis, pneumonia, and asthma. Respiratory drugs may be delivered via inhalers, nebulizers, or intravenous lines.
Inhalable & Nasal Spray:
Inhalable & nasal spray is a drug delivery technology that involves the use of a metered dose inhaler or nebulizer and a nasal applicator. The drug is dispensed in an aerosol form that comprises of particles which are small enough to get absorbed into the blood vessels lining up with the olfactory epithelium present in the nose.
Oral:
Oral drug delivery is a method of delivering drugs to patients that do not require injection. The most common route of oral drug administration is the mouth, however, it can be administered by the nose, vagina and rectum as well. Drug products that are administered orally usually dissolve or disintegrate in the mouth and are then absorbed by the gastrointestinal tract. Some drugs may also be mixed with water or another liquid for easier administration.
Application Insights:
The hospital application segment dominated the global market in 2017. The segment is expected to witness significant growth over the forecast period owing to increasing prevalence of respiratory disorders and growing number of hospitals across the globe. For instance, as per WHO, there are approximately 1 billion cases of asthma globally and 300 million people are treated with bronchodilators annually. Similarly, according to data published by Global Asthma Report Card in 2018, around 37% adults have asthma orOSA (Otitis Media & Respiratory infections). Increasing incidence rate of these diseases coupled with rising awareness about treatment is anticipated to boost demand for inhalers and other devices used for treating respiratory disorders at a global level.
Drug stores are estimated to be one of the fastest-growing segments during the forecast period due largely on increasing adoption rates among consumers seeking effective yet affordable treatments for their chronic conditions such as asthma and allergies. According to a study conducted by eHealthInsights Inc.
Regional Analysis:
North America dominated the global respiratory drug market in 2017. The presence of a large number of key players, favorable reimbursement scenario, and high healthcare expenditure are some factors responsible for its dominance. In addition, increasing prevalence of COPD is also expected to drive growth over the forecast period. According to CDC estimates in 2016 around 17 million people were diagnosed with COPD and 6 million had moderate asthma that year which is expected to grow substantially over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising disposable income leading towards improvement in healthcare infrastructure along with growing awareness about various treatment options available for respiratory disorders such as inhalable & nasal spray therapy and oral drugs among patients suffering from COPD or asthma.
Key Companies: Pfizer Inc.
Growth Factors:
- Increasing incidence of respiratory diseases such as asthma, COPD, and pneumonia.
- Growing awareness about the benefits of early diagnosis and treatment of respiratory diseases.
- Rising demand for novel and advanced therapies for the treatment of respiratory diseases.
- increasing prevalence of smoking and air pollution which are the major risk factors for developing respiratory diseases .
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Drug Market Research Report
By Type
Inhalable & Nasal Spray, Oral, Others
By Application
Hospital, Drugs Store
By Companies
GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi, Mylan, Sumitomo Dainippon, Merck, Beximco
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Drug Market Report Segments:
The global Respiratory Drug market is segmented on the basis of:
Types
Inhalable & Nasal Spray, Oral, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- AstraZeneca
- Boehringer Ingelheim
- Vertex
- Roche
- Novartis
- Teva
- Chiesi
- Mylan
- Sumitomo Dainippon
- Merck
- Beximco
Highlights of The Respiratory Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inhalable & Nasal Spray
- Oral
- Others
- By Application:
- Hospital
- Drugs Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A respiratory drug is a medication that helps to improve breathing. These drugs can be used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.
Some of the major companies in the respiratory drug market are GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi, Mylan, Sumitomo Dainippon, Merck, Beximco.
The respiratory drug market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Respiratory Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Respiratory Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Respiratory Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Respiratory Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Respiratory Drug Market Size & Forecast, 2020-2028
4.5.1 Respiratory Drug Market Size and Y-o-Y Growth
4.5.2 Respiratory Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Inhalable & Nasal Spray
5.2.2 Oral
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Respiratory Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Respiratory Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Inhalable & Nasal Spray
9.6.2 Oral
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Inhalable & Nasal Spray
10.6.2 Oral
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Inhalable & Nasal Spray
11.6.2 Oral
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Inhalable & Nasal Spray
12.6.2 Oral
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Inhalable & Nasal Spray
13.6.2 Oral
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Respiratory Drug Market: Competitive Dashboard
14.2 Global Respiratory Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 AstraZeneca
14.3.3 Boehringer Ingelheim
14.3.4 Vertex
14.3.5 Roche
14.3.6 Novartis
14.3.7 Teva
14.3.8 Chiesi
14.3.9 Mylan
14.3.10 Sumitomo Dainippon
14.3.11 Merck
14.3.12 Beximco
